EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Photobiomodulation Therapy: The Dawn of Myopia Control

Kate Gettinger iD, Yinuo Huang, Kazuo Tsubota iD, Kazuno Negishi iD, Toshihide Kurihara iD

Cells · 16.03.2026 · 15 (6) · 526

DOI: 10.3390/cells15060526 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.03.2026. Verfasst von Kate Gettinger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Photobiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Hauptthemen laut MEDLINE: Myopia, Low-Level Light Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 278 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology Japan, Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the prevalence of myopia, or near-sightedness, continues to rise globally, it becomes imperative to determine the mechanisms driving myopia so that appropriate interventions to mitigate it can be developed. Light appears to be critical for normal ocular development, and over the past several decades research has explored the connection between light exposure and myopia development. This review explores the growing field of photobiomodulation, or the use of light to modulate biological processes, to prevent myopia development. To complete this review, relevant texts published from January 1990 to December 2025 were retrieved from the PubMed database using a combination of search terms covering myopia and ocular development, light exposure conditions related to myopia, myopia development in relation to circadian and diurnal regulation, nonvisual opsins and myopia, and light-induced ocular damage. Through this review, we see that photobiomodulation offers a potential intervention to control myopia progression, but the mechanisms behind light’s influence on ocular development remain complex and incompletely understood. This review aims to summarize what is currently known to serve as a basis for future research and to delineate important findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyopiaLow-Level Light TherapyHumansAnimalsCircadian Rhythm

Stichwörter der Autor:innen

myopiamyopia preventionnonvisual opsinsphotobiomodulation

Autor:innen und Institutionen

  • Laboratory of Photobiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Department of Ophthalmology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Tsubota Laboratory, Inc., Keio Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

ORCID-Profile: Kate Gettinger, Kazuo Tsubota, Kazuno Negishi, Toshihide Kurihara

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology Japan
  • Japan Agency for Medical Research and Development
  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Gettinger, K., Huang, Y., Tsubota, K., Negishi, K., & Kurihara, T. (2026). Photobiomodulation Therapy: The Dawn of Myopia Control. Cells, 15(6), 526. https://doi.org/10.3390/cells15060526

Vancouver

Gettinger K, Huang Y, Tsubota K, Negishi K, Kurihara T. Photobiomodulation Therapy: The Dawn of Myopia Control. Cells. 2026;15(6):526. doi:10.3390/cells15060526

BibTeX
@article{Gettinger2026,
  author = {Gettinger, Kate and Huang, Yinuo and Tsubota, Kazuo and Negishi, Kazuno and Kurihara, Toshihide},
  title = {Photobiomodulation Therapy: The Dawn of Myopia Control},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {526},
  doi = {10.3390/cells15060526}
}
Kostenlos starten →